LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)

Recently, lithium salts have been considered as potential compounds for targeted therapy that can reduce tumor growth. There are a large number of publications indicating the effects of lithium on the signaling pathways used by tumor cells for growth and development, and have demonstrated that lithi...

Full description

Bibliographic Details
Main Authors: Iu. S. Taskaeva, N. P. Bgatova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2019-11-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/270
_version_ 1797269559199137792
author Iu. S. Taskaeva
N. P. Bgatova
author_facet Iu. S. Taskaeva
N. P. Bgatova
author_sort Iu. S. Taskaeva
collection DOAJ
description Recently, lithium salts have been considered as potential compounds for targeted therapy that can reduce tumor growth. There are a large number of publications indicating the effects of lithium on the signaling pathways used by tumor cells for growth and development, and have demonstrated that lithium can be used as antitumor agent in experimental oncology. The promise of using lithium salts to develop anticancer drugs is related to the fact that lithium has 2 main intracellular targets: glycogen synthase kinase-3β (GSK-3β) and inositol monophosphatase (IMPase), the inhibition of which by lithium can induce cancer cell death by apoptosis or autophagy. Lithium has been shown to block the proliferation of cancer cells by cell cycle arrest in the G2 /M phase, and also stimulates apoptosis and autophagy in cancer cells. This review summarizes data on the transport of lithium across cell membranes, characterizes its main intracellular targets and presents the results of studies in which lithium was used in experimental cancer therapy of various localization with an emphasis on signaling pathways used by cancer cells for growth and metastasis.
first_indexed 2024-03-08T14:34:33Z
format Article
id doaj.art-d297b3e178054581b55c5612bb6d5020
institution Directory Open Access Journal
issn 2410-2512
2410-2520
language Russian
last_indexed 2024-04-25T01:50:18Z
publishDate 2019-11-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj.art-d297b3e178054581b55c5612bb6d50202024-03-07T18:49:58ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202019-11-01395121810.15372/SSMJ20190502183LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)Iu. S. Taskaeva0N. P. Bgatova1Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS, Novosibirsk State UniversityResearch Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RASRecently, lithium salts have been considered as potential compounds for targeted therapy that can reduce tumor growth. There are a large number of publications indicating the effects of lithium on the signaling pathways used by tumor cells for growth and development, and have demonstrated that lithium can be used as antitumor agent in experimental oncology. The promise of using lithium salts to develop anticancer drugs is related to the fact that lithium has 2 main intracellular targets: glycogen synthase kinase-3β (GSK-3β) and inositol monophosphatase (IMPase), the inhibition of which by lithium can induce cancer cell death by apoptosis or autophagy. Lithium has been shown to block the proliferation of cancer cells by cell cycle arrest in the G2 /M phase, and also stimulates apoptosis and autophagy in cancer cells. This review summarizes data on the transport of lithium across cell membranes, characterizes its main intracellular targets and presents the results of studies in which lithium was used in experimental cancer therapy of various localization with an emphasis on signaling pathways used by cancer cells for growth and metastasis.https://sibmed.elpub.ru/jour/article/view/270experimental oncologylithium saltsgsk-3βimpaseapoptosisautophagy
spellingShingle Iu. S. Taskaeva
N. P. Bgatova
LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
Сибирский научный медицинский журнал
experimental oncology
lithium salts
gsk-3β
impase
apoptosis
autophagy
title LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
title_full LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
title_fullStr LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
title_full_unstemmed LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
title_short LITHIUM SALTS IN EXPERIMENTAL ONCOLOGY (REVIEW)
title_sort lithium salts in experimental oncology review
topic experimental oncology
lithium salts
gsk-3β
impase
apoptosis
autophagy
url https://sibmed.elpub.ru/jour/article/view/270
work_keys_str_mv AT iustaskaeva lithiumsaltsinexperimentaloncologyreview
AT npbgatova lithiumsaltsinexperimentaloncologyreview